OIA
CADL icon

OneDigital Investment Advisors’s Candel Therapeutics CADL Stock Holding History

OneDigital Investment Advisors’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,783
Closed -$47.1K – 1370
2024
Q1 		$47.1K Hold
29,783
– – ﹤0.01% 1069
2023
Q4 		$43.8K Buy
29,783
+4,355
+17% +$4.23K ﹤0.01% 1087
2023
Q3 		$23.4K Hold
25,428
– – ﹤0.01% 980
2023
Q2 		$32K Hold
25,428
– – ﹤0.01% 996
2023
Q1 		$34.3K Buy
+25,428
New +$49.6K ﹤0.01% 951

Other funds holding CADL

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OneDigital Investment Advisors's CADL Position: Q2 2024 in Review

OneDigital Investment Advisors sold out of Candel Therapeutics (CADL) in Q2 2024, closing a stake of 29,783 shares — an estimated $47.1K sold.

OneDigital Investment Advisors first reported a position in CADL in Q1 2023 and held it in 5 quarters. The position peaked at $47.1K in Q1 2024. 45 funds tracked by Wall St. Rank hold CADL as of Q2 2024.

  • OneDigital Investment Advisors reported no remaining Candel Therapeutics position as of Q2 2024 after selling out during the quarter.
  • OneDigital Investment Advisors sold 29,783 Candel Therapeutics shares in Q2 2024, an estimated $47.1K.
  • OneDigital Investment Advisors first reported a position in Candel Therapeutics in Q1 2023 and held it in 5 quarters.
  • OneDigital Investment Advisors's Candel Therapeutics position peaked at $47.1K in Q1 2024.
  • 45 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2024.

Based on OneDigital Investment Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.